Lurie Autism Institute Appoints Director, Bolstered by $50 Million Gift
Event summary
- Eric M. Morrow, MD, PhD, has been appointed founding director of the Lurie Autism Institute, effective September 1, 2026.
- The Lurie Autism Institute was launched in 2025 with a $50 million gift from the Lurie and Marks families.
- Dr. Morrow previously served on both CHOP and Penn Medicine's Autism External Scientific Advisory Boards.
- The Institute will be jointly managed by Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania.
The big picture
The creation of the Lurie Autism Institute represents a significant investment in autism research at a time when advances in genomics and AI are accelerating the pace of discovery. The $50 million endowment positions the Institute to become a major player in a field historically fragmented and lacking in therapeutic breakthroughs, but its success will depend on effective collaboration and a clear research focus.
What we're watching
- Research Focus
- Dr. Morrow's focus on translational neurogenetics and rare inherited conditions will likely shape the Institute's initial research priorities, potentially leading to a concentration on specific genetic pathways and targeted therapies.
- Collaboration Dynamics
- The success of the Institute hinges on the effective integration of CHOP and Penn Medicine's research efforts; friction between the institutions could impede progress and dilute the impact of the substantial funding.
- Therapeutic Pipeline
- Given the lack of approved therapies for core autism symptoms, the Institute's ability to translate research findings into clinical trials and ultimately approved treatments will be a key measure of its long-term success.
Related topics